Clinical Trial Update: Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL) [Phase 2]

View source ↗

Summary

Phase 2 study of fedratinib in myeloproliferative neoplasms, chronic neutrophilic leukemia, and myelodysplastic syndromes; the trial is not recruiting and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• Neutrophilic Leukemia

Drugs mentioned

• fedratinib (fedratinib)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Myeloproliferative Neoplasm, Chronic Neutrophilic Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-04-17